In contrast, CD40 demonstrated a protective effect through two analytical methods (MR Egger and weighted median), showing a negative correlation with NSCLC risk (OR = 0.857 and 0.894, both p = 0.015). This evidence concerns the gene CD40 and non-small cell lung carcinoma.